Redoxon by Albert Szent-Györgyi that isolated vitamin C from capsicum (peppers). After the sale of the Reichstein process patent to Hoffmann-La Roche, this process became the basis of the corporation's large-scale production of vitamin C. The present-day Redoxon tablets are compounded from ascorbic acid and sodium bicarbonate. When these are added to water, they react to produce sodium ascorbate, water and carbon dioxide, thus producing an effervescence. Some versions of Redoxon contain additional nutrients. Redoxon Redoxon was the brand name of the first artificially synthesized ascorbic acid (vitamin C). Redoxon was first marketed to the general public by Hoffman-La Roche in
Vitamin B12 leading to vitamin B deficiency. Protein-bound vitamin B must be released from the proteins by the action of digestive proteases in both the stomach and small intestine. Gastric acid releases the vitamin from food particles; therefore antacid and acid-blocking medications (especially proton-pump inhibitors) may inhibit absorption of B. B taken in a low-solubility, non-chewable supplement pill form may bypass the mouth and stomach and not mix with gastric acids, but acids are not necessary for the absorption of free B not bound to protein; acid is necessary only to recover naturally-occurring vitamin B from foods. R-protein (also known as haptocorrin